迅速検査の市場規模、シェア、動向分析レポート製品別（機器、消耗品）、技術別（免疫測定、分子診断）、用途別、最終用途別、地域別、セグメント別予測、2023年～2030年

迅速検査の市場成長と動向

Grand View Research, Inc.の最新レポートによると、迅速検査の世界市場規模は、2023年から2030年にかけてCAGR8.6%を記録し、2030年までに25億米ドルに達すると予測されています。高齢化人口の増加、対象疾患の有病率の上昇、ポイントオブケア施設に対する需要の高まりが、迅速診断分野の成長を促す主な要因となっています。また、技術的に高度な製品の発売が、この分野をさらに後押ししています。

迅速診断は、迅速かつ効果的な結果を提供することにより、疾病検査において重要な役割を担っています。敗血症や結核、インフルエンザなどの呼吸器系疾患などの感染症が増加していることが、予測期間中に市場を牽引することが予想されます。WHOによると、結核は世界の死因のトップ10に入っており、2021年には約1,000万人の結核の新規患者が記録され、約140万人の死因を占めています。

さらに、世界保健機関（WHO）の発表によると、毎年約5,000万人が敗血症に罹患していると推定されます。さらに、薬剤耐性感染症の増加も、市場成長のインパクト促進要因のひとつです。したがって、このような疾病の負担増が診断の需要を高め、迅速検査市場に拍車をかけているのです。

この分野では、低コストで精度が高く、携帯性に優れた製品を得るために、急速な技術進歩が見られます。Roche Diagnostics社やAbbott Laboratories社などの企業は、使い勝手が良く、患者が容易に導入できる携帯型製品を発表しています。さらに、市場における革新的な製品の発売は、業界プレーヤーによる研究開発およびパートナーシッププログラムの増加にも起因しています。

例えば、2021年4月、Chembio Diagnostics, Inc.は、米国市場において、迅速なポイントオブケアCOVID-19/Flu A&Bテストを発表しました。この製品は、CLIA免除ライセンスとともにラボでの使用が承認されており、従来型＆分散型の環境において、より短いターンアラウンドタイムでインフルエンザとCOVID-19を鑑別するのに適しています。

市場の主要企業は、新製品の発売、施設の拡張、M&Aなどのイニシアチブを戦略的に取っており、これが迅速診断分野の成長をさらに後押ししています。例えば、2022年7月、Cytovale社は、10分で結果を出すことができる迅速な敗血症リスク層別化検査、IntelliSepの510（k）出願中を発表しました。さらに、2022年4月、bioMerieuxはSpecific Diagnosticsの買収を発表しました。この買収により、bioMerieuxはSpecific Diagnosticsの迅速抗菌剤感受性試験（AST）システムの優位性を獲得することが期待されます。

迅速検査市場のレポートハイライト

製品別では、消耗品セグメントが2022年の市場を独占し、売上シェアは68.08%でした。上気道疾患の検査需要の高まりと、多数のPoCアッセイの製品化が、セグメントを牽引する主要因の一つ

2022年、技術分野では免疫測定法が52.45%のシェアを占め、この分野を支配しています。イムノアッセイは、高い検査効果と精度を提供するため、一般的に製品の普及率が高いです。ただし、予測期間中は分子診断分野が最も速い成長を遂げると予想される

2022年のアプリケーション別では、製品承認の増加や肺を冒す感染症の発生率の高さから、上気道感染症分野がこの分野を支配しています。ただし、抗生物質耐性感染症分野が予測期間中に最も速い成長を示すと予想される

最終用途に基づくと、病院とクリニックは確立されたセグメントであり、2022年の収益に大きく寄与しています。しかし、自宅で患者に提供されるPOCTの費用対効果や快適性から、自宅での使用は有利なセグメントとなっています。

地域別では、2022年の迅速検査の世界市場で北米が最も高い収益シェアを占めています。しかし、アジア太平洋は予測期間中に最も急速に成長する地域となる見込みです

目次

第1章 調査手法と範囲

• 市場セグメンテーションと範囲
  • セグメントの範囲
  • 地域範囲
• 調査手法
• 情報調達
  • 購入したデータベース：
  • GVRの内部データベース
  • 二次情報
  • 1次調査
  • 1次調査の詳細
• 情報またはデータ分析
  • データ分析モデル
• 市場の策定と検証
• モデルの詳細
  • コモディティフロー分析
    • アプローチ：商品フローアプローチ
• 調査の仮定
• 二次情報のリスト
• 略語一覧
• 目的

第2章 エグゼクティブサマリー

• 市場の見通し

第3章 迅速なテスト診断市場の変数、動向、および範囲

• 市場系列の見通し
  • 親市場の見通し
• 浸透と成長の見通しのマッピング
• 規制および償還の枠組み
• 市場促進要因分析
  • 自己検査およびポイントオブケア製品の採用の増加、およびCLIA免除検査のイントロダクション
  • 高齢者人口基盤の拡大
  • 先進技術対応製品のイントロダクション
  • 標的疾患の有病率の増加
• 市場抑制要因分析
  • プライマリケア設定に対するあいまいな規制と償還の枠組みの存在
  • 迅速なテストの感度と精度
• 業界分析- ポーターズ
• 参入障壁
• PESTLE分析、要因別（政治と法律、経済、技術）
• 市場参入戦略

第4章 迅速検査市場：セグメント分析、製品別、2018年から2030年（百万米ドル）

• 迅速検査市場：製品の変動分析
• 楽器
• 消耗品
• その他

第5章 迅速検査市場：セグメント分析、テクノロジー別、2018年から2030年（百万米ドル）

• 迅速検査市場：技術変動分析
• 分子診断学
• イムノアッセイ
• その他

第6章 迅速検査市場：セグメント分析、アプリケーションタイプ別、2018年から2030年（百万米ドル）

• 迅速検査市場：アプリケーションタイプの変動分析
• 上気道感染症
  • インフルエンザとパラインフルエンザウイルス
  • RSウイルス
  • 連鎖球菌
• 抗生物質- 耐性感染症（MRSA、肺炎球菌など）
• 敗血症
  • 細菌性敗血症
  • 真菌性敗血症
  • その他

第7章 迅速検査市場：セグメント分析、最終使用別、2018年から2030年（百万米ドル）

• 迅速検査市場：エンドユースの変動分析
• 病院と診療所
• 研究所
• 在宅検査など

第8章 迅速検査市場：セグメント分析、地域別、2018年から2030年（百万米ドル）

• 地域市場シェア分析、2022年および2030年
• 地域市場のスナップショット
• 市場規模、予測、収益、トレンド分析、2022年から2030年
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • スペイン
  • フランス
  • イタリア
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東およびアフリカ（Mea）
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 迅速検査市場：競合分析

• 主要な市場参入企業別最近の動向と影響分析
  • 新製品の発売
  • 合併と買収
  • パートナーシップと戦略的コラボレーション
  • カンファレンスとキャンペーン
• 会社の分類
  • イノベーター
  • 市場のリーダー
• ベンダー情勢
  • 主要なディストリビューターとチャネルパートナーのリスト
  • 主要企業の市場シェア分析、2022年
• 非公開会社
  • 主要新興企業一覧
• 公開会社
  • 企業の市況分析
  • 競合ダッシュボード分析
• 企業プロファイル
  • Abbott
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • BD（Becton, Dickinson and Company）
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • bioMerieux SA
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • DiaSorin SpA
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Danaher Corporation
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Thermo Fisher Scientific, Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • F. Hoffmann-La Roche Ltd
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviation
• Table 3 List of Parameters
• Table 4 List of Distributors
• Table 5 Global Rapid tests market, By Region, 2018 - 2030 (USD Million)
• Table 6 Global Rapid tests market, By Product, 2018 - 2030 (USD Million)
• Table 7 Global Rapid tests market, By Technology, 2018 - 2030 (USD Million)
• Table 8 Global Rapid tests market, By Application, 2018 - 2030 (USD Million)
• Table 9 Global Rapid tests market, By End-use, 2018 - 2030 (USD Million)
• Table 10 North America Rapid tests market, By Country, 2018 - 2030 (USD Million)
• Table 11 North America Rapid tests market, By Product, 2018 - 2030 (USD Million)
• Table 12 North America Rapid tests market, By Technology, 2018 - 2030 (USD Million)
• Table 13 North America Rapid tests market, By Application, 2018 - 2030 (USD Million)
• Table 14 North America Rapid tests market, By End-use, 2018 - 2030 (USD Million)
• Table 15 U.S. Rapid tests market, By Product, 2018 - 2030 (USD Million)
• Table 16 U.S. Rapid tests market, By Technology, 2018 - 2030 (USD Million)
• Table 17 U.S. Rapid tests market, By Application, 2018 - 2030 (USD Million)
• Table 18 U.S. Rapid tests market, By End-use, 2018 - 2030 (USD Million)
• Table 19 Canada Rapid tests market, By Product, 2018 - 2030 (USD Million)
• Table 20 Canada Rapid tests market, By Technology, 2018 - 2030 (USD Million)
• Table 21 Canada Rapid tests market, By Application, 2018 - 2030 (USD Million)
• Table 22 Canada Rapid tests market, By End-use, 2018 - 2030 (USD Million)
• Table 23 Europe Rapid tests market, By Country, 2018 - 2030 (USD Million)
• Table 24 Europe Rapid tests market, By Product, 2018 - 2030 (USD Million)
• Table 25 Europe Rapid tests market, By Technology, 2018 - 2030 (USD Million)
• Table 26 Europe Rapid tests market, By Application, 2018 - 2030 (USD Million)
• Table 27 Europe Rapid tests market, By End-use, 2018 - 2030 (USD Million)
• Table 28 Germany Rapid tests market, By Product, 2018 - 2030 (USD Million)
• Table 29 Germany Rapid tests market, By Technology, 2018 - 2030 (USD Million)
• Table 30 Germany Rapid tests market, By Application, 2018 - 2030 (USD Million)
• Table 31 Germany Rapid tests market, By End-use, 2018 - 2030 (USD Million)
• Table 32 UK Rapid tests market, By Product, 2018 - 2030 (USD Million)
• Table 33 UK Rapid tests market, By Technology, 2018 - 2030 (USD Million)
• Table 34 UK Rapid tests market, By Application, 2018 - 2030 (USD Million)
• Table 35 UK Rapid tests market, By End-use, 2018 - 2030 (USD Million)
• Table 36 France Rapid tests market, By Product, 2018 - 2030 (USD Million)
• Table 37 France Rapid tests market, By Technology, 2018 - 2030 (USD Million)
• Table 38 France Rapid tests market, By Application, 2018 - 2030 (USD Million)
• Table 39 France Rapid tests market, By End-use, 2018 - 2030 (USD Million)
• Table 40 Italy Rapid tests market, By Product, 2018 - 2030 (USD Million)
• Table 41 Italy Rapid tests market, By Technology, 2018 - 2030 (USD Million)
• Table 42 Italy Rapid tests market, By Application, 2018 - 2030 (USD Million)
• Table 43 Italy Rapid tests market, By End-use, 2018 - 2030 (USD Million)
• Table 44 Spain Rapid tests market, By Product, 2018 - 2030 (USD Million)
• Table 45 Spain Rapid tests market, By Technology, 2018 - 2030 (USD Million)
• Table 46 Spain Rapid tests market, By Application, 2018 - 2030 (USD Million)
• Table 47 Spain Rapid tests market, By End-use, 2018 - 2030 (USD Million)
• Table 48 Denmark Rapid tests market, By Product, 2018 - 2030 (USD Million)
• Table 49 Denmark Rapid tests market, By Technology, 2018 - 2030 (USD Million)
• Table 50 Denmark Rapid tests market, By Application, 2018 - 2030 (USD Million)
• Table 51 Denmark Rapid tests market, By End-use, 2018 - 2030 (USD Million)
• Table 52 Sweden Rapid tests market, By Product, 2018 - 2030 (USD Million)
• Table 53 Sweden Rapid tests market, By Technology, 2018 - 2030 (USD Million)
• Table 54 Sweden Rapid tests market, By Application, 2018 - 2030 (USD Million)
• Table 55 Sweden Rapid tests market, By End-use, 2018 - 2030 (USD Million)
• Table 56 Norway Rapid tests market, By Product, 2018 - 2030 (USD Million)
• Table 57 Norway Rapid tests market, By Technology, 2018 - 2030 (USD Million)
• Table 58 Norway Rapid tests market, By Application, 2018 - 2030 (USD Million)
• Table 59 Norway Rapid tests market, By End-use, 2018 - 2030 (USD Million)
• Table 60 Asia Pacific Rapid tests market, By Country, 2018 - 2030 (USD Million)
• Table 61 Asia Pacific Rapid tests market, By Product, 2018 - 2030 (USD Million)
• Table 62 Asia Pacific Rapid tests market, By Technology, 2018 - 2030 (USD Million)
• Table 63 Asia Pacific Rapid tests market, By Application, 2018 - 2030 (USD Million)
• Table 64 Asia Pacific Rapid tests market, By End-use, 2018 - 2030 (USD Million)
• Table 65 Japan Rapid tests market, By Product, 2018 - 2030 (USD Million)
• Table 66 Japan Rapid tests market, By Technology, 2018 - 2030 (USD Million)
• Table 67 Japan Rapid tests market, By Application, 2018 - 2030 (USD Million)
• Table 68 Japan Rapid tests market, By End-use, 2018 - 2030 (USD Million)
• Table 69 China Rapid tests market, By Product, 2018 - 2030 (USD Million)
• Table 70 China Rapid tests market, By Technology, 2018 - 2030 (USD Million)
• Table 71 China Rapid tests market, By Application, 2018 - 2030 (USD Million)
• Table 72 China Rapid tests market, By End-use, 2018 - 2030 (USD Million)
• Table 73 India Rapid tests market, By Product, 2018 - 2030 (USD Million)
• Table 74 India Rapid tests market, By Technology, 2018 - 2030 (USD Million)
• Table 75 India Rapid tests market, By Application, 2018 - 2030 (USD Million)
• Table 76 India Rapid tests market, By End-use, 2018 - 2030 (USD Million)
• Table 77 South Korea Rapid tests market, By Product, 2018 - 2030 (USD Million)
• Table 78 South Korea Rapid tests market, By Technology, 2018 - 2030 (USD Million)
• Table 79 South Korea Rapid tests market, By Application, 2018 - 2030 (USD Million)
• Table 80 South Korea Rapid tests market, By End-use, 2018 - 2030 (USD Million)
• Table 81 Australia Rapid tests market, By Product, 2018 - 2030 (USD Million)
• Table 82 Australia Rapid tests market, By Technology, 2018 - 2030 (USD Million)
• Table 83 Australia Rapid tests market, By Application, 2018 - 2030 (USD Million)
• Table 84 Australia Rapid tests market, By End-use, 2018 - 2030 (USD Million)
• Table 85 Thailand Rapid tests market, By Product, 2018 - 2030 (USD Million)
• Table 86 Thailand Rapid tests market, By Technology, 2018 - 2030 (USD Million)
• Table 87 Thailand Rapid tests market, By Application, 2018 - 2030 (USD Million)
• Table 88 Thailand Rapid tests market, By End-use, 2018 - 2030 (USD Million)
• Table 89 Latin America Rapid tests market, By Country, 2018 - 2030 (USD Million)
• Table 90 Latin America Rapid tests market, By Product, 2018 - 2030 (USD Million)
• Table 91 Latin America Rapid tests market, By Technology, 2018 - 2030 (USD Million)
• Table 92 Latin America Rapid tests market, By Application, 2018 - 2030 (USD Million)
• Table 93 Latin America Rapid tests market, By End-use, 2018 - 2030 (USD Million)
• Table 94 Brazil Rapid tests market, By Product, 2018 - 2030 (USD Million)
• Table 95 Brazil Rapid tests market, By Technology, 2018 - 2030 (USD Million)
• Table 96 Brazil Rapid tests market, By Application, 2018 - 2030 (USD Million)
• Table 97 Brazil Rapid tests market, By End-use, 2018 - 2030 (USD Million)
• Table 98 Mexico Rapid tests market, By Product, 2018 - 2030 (USD Million)
• Table 99 Mexico Rapid tests market, By Technology, 2018 - 2030 (USD Million)
• Table 100 Mexico Rapid tests market, By Application, 2018 - 2030 (USD Million)
• Table 101 Mexico Rapid tests market, By End-use, 2018 - 2030 (USD Million)
• Table 102 Argentina Rapid tests market, By Product, 2018 - 2030 (USD Million)
• Table 103 Argentina Rapid tests market, By Technology, 2018 - 2030 (USD Million)
• Table 104 Argentina Rapid tests market, By Application, 2018 - 2030 (USD Million)
• Table 105 Argentina Rapid tests market, By End-use, 2018 - 2030 (USD Million)
• Table 106 Middle East & Africa Rapid tests market, By Country, 2018 - 2030 (USD Million)
• Table 107 Middle East & Africa Rapid tests market, By Product, 2018 - 2030 (USD Million)
• Table 108 Middle East & Africa Rapid tests market, By Technology, 2018 - 2030 (USD Million)
• Table 109 Middle East & Africa Rapid tests market, By Application, 2018 - 2030 (USD Million)
• Table 110 Middle East & Africa Rapid tests market, By End-use, 2018 - 2030 (USD Million)
• Table 111 Saudi Arabia Rapid tests market, By Product, 2018 - 2030 (USD Million)
• Table 112 Saudi Arabia Rapid tests market, By Technology, 2018 - 2030 (USD Million)
• Table 113 Saudi Arabia Rapid tests market, By Application, 2018 - 2030 (USD Million)
• Table 114 Saudi Arabia Rapid tests market, By End-use, 2018 - 2030 (USD Million)
• Table 115 South Africa Rapid tests market, By Product, 2018 - 2030 (USD Million)
• Table 116 South Africa Rapid tests market, By Technology, 2018 - 2030 (USD Million)
• Table 117 South Africa Rapid tests market, By Application, 2018 - 2030 (USD Million)
• Table 118 South Africa Rapid tests market, By End-use, 2018 - 2030 (USD Million)
• Table 119 UAE Rapid tests market, By Product, 2018 - 2030 (USD Million)
• Table 120 UAE Rapid tests market, By Technology, 2018 - 2030 (USD Million)
• Table 121 UAE Rapid tests market, By Application, 2018 - 2030 (USD Million)
• Table 122 UAE Rapid tests market, By End-use, 2018 - 2030 (USD Million)
• Table 123 Kuwait Rapid tests market, By Product, 2018 - 2030 (USD Million)
• Table 124 Kuwait Rapid tests market, By Technology, 2018 - 2030 (USD Million)
• Table 125 Kuwait Rapid tests market, By Application, 2018 - 2030 (USD Million)
• Table 126 Kuwait Rapid tests market, By End-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Rapid tests market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value - chain - based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market outlook (2022)
• Fig. 10 Penetration and growth prospect mapping
• Fig. 11 Market driver impact
• Fig. 12 Shift in POC molecular diagnostic trends
• Fig. 13 Market restraint impact
• Fig. 14 Porter's Five Forces Analysis
• Fig. 15 KoL split, by geography
• Fig. 16 Rapid tests product outlook: Key takeaways
• Fig. 17 Rapid tests market: Product movement analysis (USD Million)
• Fig. 18 Instruments market, 2018 - 2030 (USD Million)
• Fig. 19 Consumables market, 2018 - 2030 (USD Million)
• Fig. 20 Others market, 2018 - 2030 (USD Million)
• Fig. 21 Rapid tests technology outlook: Key takeaways
• Fig. 22 Rapid tests market: Technology movement analysis (USD Million)
• Fig. 23 Molecular diagnostics market, 2018 - 2030 (USD Million)
• Fig. 24 Immunoassay market, 2018 - 2030 (USD Million)
• Fig. 25 Others market, 2018 - 2030 (USD Million)
• Fig. 26 Rapid tests application outlook: Key takeaways
• Fig. 27 Rapid tests market: Application type movement analysis (USD Million)
• Fig. 28Upper respiratory tract infections market, 2018 - 2030 (USD Million)
• Fig. 29 Influenza and parainfluenza virus market, 2018 - 2030 (USD Million)
• Fig. 30 Respiratory syncytial virus market, 2018 - 2030 (USD Million)
• Fig. 31 Streptococcus market, 2018 - 2030 (USD Million)
• Fig. 32 Antibiotic - resistant infections (MRSA, Streptococcus pneumonia, and others) market, 2018 - 2030 (USD Million)
• Fig. 33 Sepsis market, 2018 - 2030 (USD Million)
• Fig. 34 Bacterial Sepsis market, 2018 - 2030 (USD Million)
• Fig. 35 Fungal sepsis market, 2018 - 2030 (USD Million)
• Fig. 36 Others market, 2018 - 2030 (USD Million)
• Fig. 37 Rapid tests end - use outlook: Key takeaways
• Fig. 38 Rapid tests market: End - use movement analysis (USD Million)
• Fig. 39 Hospitals & clinics market, 2018 - 2030 (USD Million)
• Fig. 40 Laboratories market, 2018 - 2030 (USD Million)
• Fig. 41 At - home testing and others market, 2018 - 2030 (USD Million)
• Fig. 42 Regional outlook, 2021 & 2030
• Fig. 43 Regional marketplace: Key takeaways
• Fig. 44 North America
• Fig. 45 North America Rapid tests market Estimates & Forecasts, 2018 - 2030
• Fig. 46 U.S.
• Fig. 47 U.S. Rapid tests market Estimates & Forecasts, 2018 - 2030
• Fig. 48Canada
• Fig. 49 Canada Rapid tests market Estimates & Forecasts, 2018 - 2030
• Fig. 50 Europe
• Fig. 51 Europe Rapid tests market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 52 UK
• Fig. 53 UK Rapid tests market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Germany
• Fig. 55 Germany Rapid tests market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Spain
• Fig. 57 Spain Rapid tests market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 58 France
• Fig. 59 France Rapid tests market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Italy
• Fig. 61 Italy Rapid tests market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 62 Spain
• Fig. 63 Spain Rapid tests market Estimates & Forecasts, 2018 - 2030
• Fig. 64 Denmark
• Fig. 65 Denmark Rapid tests market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 66 Sweden
• Fig. 67 Sweden Rapid tests market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 68 Norway
• Fig. 69 Norway Rapid tests market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 70 Rest of Europe
• Fig. 71 Rest of Europe Rapid tests market Estimates & Forecasts, 2018 - 2030 (USD Million
• Fig. 72 Asia Pacific
• Fig. 73 Asia Pacific Rapid tests market Estimates & Forecasts, 2018 - 2030
• Fig. 74 Japan
• Fig. 75 Japan Rapid tests market Estimates & Forecasts, 2018 - 2030
• Fig. 76 China
• Fig. 77 China Rapid tests market Estimates & Forecasts, 2018 - 2030
• Fig. 78 India
• Fig. 79 India Rapid tests market Estimates & Forecasts, 2018 - 2030
• Fig. 80 South Korea
• Fig. 81 South Korea Rapid tests market Estimates & Forecasts, 2018 - 2030
• Fig. 82 Australia
• Fig. 83 Australia Rapid tests market Estimates & Forecasts, 2018 - 2030
• Fig. 84 Thailand
• Fig. 85 Thailand Rapid tests market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 86 Rest of APAC
• Fig. 87 Rest of APAC Rapid tests market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 88 Latin America
• Fig. 89 Latin America Rapid tests market Estimates & Forecasts, 2018 - 2030
• Fig. 90Brazil
• Fig. 91 Brazil Rapid tests market Estimates & Forecasts, 2018 - 2030
• Fig. 92 Mexico
• Fig. 93 Mexico Rapid tests market Estimates & Forecasts, 2018 - 2030
• Fig. 94 Argentina
• Fig. 95 Argentina Rapid tests market Estimates & Forecasts, 2018 - 2030
• Fig. 96 Rest of LATAM
• Fig. 97 Rest of LATAM Rapid tests market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 98 Middle East & Africa
• Fig. 99 Middle East and Africa Rapid tests market Estimates & Forecasts, 2018 - 2030
• Fig. 100 South Africa
• Fig. 101 South Africa Rapid tests market Estimates & Forecasts, 2018 - 2030
• Fig. 102 Saudi Arabia
• Fig. 103 Saudi Arabia Rapid tests market Estimates & Forecasts, 2018 - 2030
• Fig. 104 UAE
• Fig. 105 UAE Rapid tests market Estimates & Forecasts, 2018 - 2030
• Fig. 106 Kuwait
• Fig. 107 Kuwait Rapid tests market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 108 Rest of MEA
• Fig. 109 Rest of MEA Rapid tests market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 110Company market share analysis - Rapid diagnostic market, 2022
• Fig. 111 Company market position analysis,2022
• Fig. 112 Company market position analysis
• Fig. 113 Competitive Dashboard analysis
• Fig. 114 Regional network map

Rapid Tests Market Growth & Trends:

The global rapid tests market size is expected to reach USD 2.50 billion by 2030, registering a CAGR of 8.6% from 2023 to 2030, according to a new report by Grand View Research, Inc. Increase in aging population, rising prevalence of target diseases, and growing demand for point of care facilities are the key factors driving the rapid diagnostics space growth. In addition, the launch of technologically advanced products is further boosting this space.

Rapid diagnostics play an important role in disease testing by rendering quick and effective results. The growing prevalence of infectious diseases like sepsis and respiratory diseases, such as tuberculosis and influenza, is expected to drive the market during the forecast period. According to WHO, tuberculosis is among the top 10 causes of death globally; about 10.0 million new cases of tuberculosis were recorded in 2021, accounting for approximately 1.4 million deaths.

Moreover, as per World Health Organization (WHO), around 50.0 million people are estimated to be affected by sepsis every year. Furthermore, the rise in drug-resistant infections is another impact-rendering driver of market growth. Therefore, the rising burden of such diseases is increasing the demand for diagnostics and fueling the rapid tests market.

The space is witnessing rapid technological advancements to obtain low-cost, improved accuracy, and highly portable products. Companies such as Roche Diagnostics and Abbott Laboratories have introduced portable products that are user-friendly and therefore can be easily adopted by patients. Moreover, innovative product launches in the market are also due to the rising number of R&D and partnership programs by industry players.

For instance, in April 2021, Chembio Diagnostics, Inc. introduced a rapid point-of-care COVID-19/Flu A&B test in the U.S. market. This product is approved for laboratory use along with a CLIA-waived license, which is suitable for differentiating between influenza and COVID-19 in a shorter turnaround time in traditional & decentralized settings.

Key market players are strategically taking initiatives such as launching novel products, facility expansions, and mergers and acquisitions, which are further driving the rapid diagnostics space growth. For instance, in July 2022, Cytovale announced 510(k) pending for its rapid sepsis risk stratification test, IntelliSep, which can produce results in 10 minutes. Moreover, in April 2022, bioMerieux announced the acquisition of Specific Diagnostics. Through this acquisition, bioMerieux is expected to gain the advantage of Specific Diagnostics' rapid Antimicrobial Susceptibility Test (AST) system.

Rapid Tests Market Report Highlights:

• By product, the consumables segment dominated the market in 2022, with a revenue share of 68.08%. Growing demand for the testing of upper respiratory diseases and commercialization of a number of PoC assays are some of the key factors driving the segment

• In 2022, immunoassay dominated the space with a 52.45% share in the technology segment. Immunoassays typically have high product penetration as they offer higher testing efficacy and accuracy. However, the molecular diagnostics segment is expected to witness the fastest growth during the forecast period

• In 2022, by application, the upper respiratory tract infections segment dominated the space, due to the increase in product approvals and high incidences of infectious diseases that affect the lungs. However, the antibiotic-resistant infections segment is expected to exhibit the fastest growth during the forecast period

• Based on end-use, hospitals and clinics are well-established segments that have contributed significantly to revenue in 2022. However, the at-home setting is a lucrative segment owing to the cost-effectiveness and comfort level of POCT provided to patients at home

• By region, North America had the highest revenue share in the global rapid tests market in 2022. However, Asia Pacific is expected to be the fastest-growing region during the forecast period

Table of Contents

Chapter 1 Methodology And Scope

• 1.1 Market Segmentation And Scope
  • 1.1.1 Segment Scope
  • 1.1.2 Regional Scope
  • 1.1.3 Estimates And Forecast Timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased Database:
  • 1.3.2 GVR's Internal Database
  • 1.3.3 Secondary Sources
  • 1.3.4 Primary Research
  • 1.3.5 Details Of Primary Research
• 1.4 Information Or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis
    • 1.6.1.1 Approach: Commodity Flow Approach
• 1.7 Research Assumptions
• 1.8 List Of Secondary Sources
• 1.9 List Of Abbreviations
• 1.10 Objectives
  • 1.10.1 Objective 1
  • 1.10.2 Objective 2
  • 1.10.3 Objective 3
  • 1.10.4 Objective 4

Chapter 2 Executive Summary

• 2.1 Market Outlook

Chapter 3 Rapid Tests Diagnostics Market Variables, Trends, And Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
• 3.2 Penetration And Growth Prospect Mapping
• 3.3 Regulatory And Reimbursement Framework
• 3.4 Market Driver Analysis
  • 3.4.1 Increasing Adoption Of Self - Testing & Point - Of - Care Products, And Introduction Of CLIA Waived Tests
  • 3.4.2 Growing Geriatric Population Base
  • 3.4.3 Introduction Of Advance Technology Enabled Products
  • 3.4.4 Growing Prevalence Of Target Diseases
• 3.5 Market Restraint Analysis
  • 3.5.1 Presence Of Ambiguous Regulatory And Reimbursement Framework For Primary Care Setting
  • 3.5.2 Rapid Tests Sensitivity And Accuracy
• 3.6 Industry Analysis - Porter's
• 3.7 Barriers To Entry
• 3.8 PESTLE Analysis, By Factor (Political & Legal, Economic, And Technological)
• 3.9 Market Entry Strategies

Chapter 4 Rapid Tests Market: Segment Analysis, By Product, 2018 - 2030 (USD Million)

• 4.1 Rapid Tests Market: Product Movement Analysis
• 4.2 Instruments
  • 4.2.1 Instruments Market, 2018 - 2030 (USD Million)
• 4.3 Consumables
  • 4.3.1 Consumables Market, 2018 - 2030 (USD Million)
• 4.4 Others
  • 4.4.1 Others Market, 2018 - 2030 (USD Million)

Chapter 5 Rapid Tests Market: Segment Analysis, By Technology, 2018 - 2030 (USD Million)

• 5.1 Rapid Tests Market: Technology Movement Analysis
• 5.2 Molecular Diagnostics
  • 5.2.1 Molecular Diagnostics Market, 2018 - 2030 (USD Million)
• 5.3 Immunoassay
  • 5.3.1 Immunoassay Market, 2018 - 2030 (USD Million)
• 5.4 Others
  • 5.4.1 Others Market, 2018 - 2030 (USD Million)

Chapter 6 Rapid Tests Market: Segment Analysis, By Application Type, 2018 - 2030 (USD Million)

• 6.1 Rapid Tests Market: Application Type Movement Analysis
• 6.2 Upper Respiratory Tract Infections
  • 6.2.1 Upper Respiratory Tract Infections Market, 2018 - 2030 (USD Million)
  • 6.2.2 Influenza And Parainfluenza Virus
    • 6.2.2.1 Influenza And Parainfluenza Virus Market, 2018 - 2030 (USD Million)
  • 6.2.3 Respiratory Syncytial Virus
    • 6.2.3.1 Respiratory Syncytial Virus Market, 2018 - 2030 (USD Million)
  • 6.2.4 Streptococcus
    • 6.2.4.1 Streptococcus Market, 2018 - 2030 (USD Million)
• 6.3 Antibiotic - Resistant Infections (MRSA, Streptococcus Pneumonia, And Others)
  • 6.3.1 Antibiotic - Resistant Infections (MRSA, Streptococcus Pneumoniae, And Others) Market, 2018 - 2030 (USD Million)
• 6.4 Sepsis
  • 6.4.1 Sepsis Market, 2018 - 2030 (USD Million)
    • 6.4.1.1 Bacterial Sepsis
    • 6.4.1.1.1 Bacterial Sepsis Market, 2018 - 2030 (USD Million)
    • 6.4.1.2 Fungal Sepsis
    • 6.4.1.2.1 Fungal Sepsis Market, 2018 - 2030 (USD Million)
    • 6.4.1.3 Others
    • 6.4.1.3.1 Others Market, 2018 - 2030 (USD Million)

Chapter 7 Rapid Tests Market: Segment Analysis, By End - Use, 2018 - 2030 (USD Million)

• 7.1 Rapid Tests Market: End - Use Movement Analysis
• 7.2 Hospitals & Clinics
  • 7.2.1 Hospitals & Clinics Market, 2018 - 2030 (USD Million)
• 7.3 Laboratories
  • 7.3.1 Laboratories Market, 2018 - 2030 (USD Million)
• 7.4 At - Home Testing And Others
  • 7.4.1 At - Home Testing And Others Market, 2018 - 2030 (USD Million)

Chapter 8 Rapid Tests Market: Segment Analysis, By Region, 2018 - 2030 (USD Million)

• 8.1 Regional Market Share Analysis, 2022 & 2030
• 8.2 Regional Market Snapshot
• 8.3 Market Size, & Forecasts, Revenue And Trend Analysis, 2022 To 2030
• 8.4 North America
  • 8.4.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.4.2 U.S.
    • 8.4.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.4.3 Canada
    • 8.4.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 8.5 Europe
  • 8.5.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.5.2 Uk
    • 8.5.2.1 Uk Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.5.3. Germany
    • 8.5.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.5.4 Spain
    • 8.5.4.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.5.5 France
    • 8.5.5.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.5.6 Italy
    • 8.5.6.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.5.7 Denmark
    • 8.5.7.1 Denmark Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.5.8 Sweden
    • 8.5.8.1 Sweden Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.5.9 Norway
    • 8.5.9.1 Norway Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 8.6 Asia Pacific
  • 8.6.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.6.2 Japan
    • 8.6.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.6.3 China
    • 8.6.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.6.4 India
    • 8.6.4.1 India Market Estimates And Forecast, 2018 - 2030
  • 8.6.5 Australia
    • 8.6.5.1 Australia Market Estimates And Forecast, 2018 - 2030
  • 8.6.6 South Korea
    • 8.6.6.1 South Korea Market Estimates And Forecast, 2018 - 2030
  • 8.6.7 Thailand
    • 8.6.7.1 Thailand Market Estimates And Forecast, 2018 - 2030
• 8.7 Latin America
  • 8.7.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.7.2 Brazil
    • 8.7.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.7.3 Mexico
    • 8.7.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.7.4 Argentina
    • 8.7.4.1 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 8.8 Middle East & Africa (Mea)
  • 8.8.1 Middle East & Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.8.2 South Africa
    • 8.8.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.8.3 Saudi Arabia
    • 8.8.6.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.8.4 UAE
    • 8.8.4.1 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.8.5 Kuwait
    • 8.8.5.1 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9 Rapid tests market: Competitive Analysis

• 9.1 Recent Developments and Impact Analysis, by Key Market Participants
  • 9.1.1 New Product Launches
  • 9.1.2 Mergers and Acquisitions
  • 9.1.3 Partnerships and Strategic Collaborations
  • 9.1.4 Conferences and Campaigns
• 9.2 Company Categorization
  • 9.2.1 Innovators
  • 9.2.2 Market Leaders
• 9.3 Vendor Landscape
  • 9.3.1 List of key distributors and channel partners
  • 9.3.2 Key company market share analysis, 2022
• 9.4 Private Companies
  • 9.4.1 List of key emerging companies
• 9.5 Public Companies
  • 9.5.1 Company market position analysis
  • 9.5.2 Competitive dashboard analysis
• 9.6 Company Profiles
  • 9.6.1 Abbott
    • 9.6.1.1 Company overview
    • 9.6.1.2 Financial performance
    • 9.6.1.3 Product benchmarking
    • 9.6.1.4 Strategic initiatives
  • 9.6.2 BD (Becton, Dickinson and Company)
    • 9.6.2.1 Company overview
    • 9.6.2.2 Financial performance
    • 9.6.2.3 Product benchmarking
    • 9.6.2.4 Strategic initiatives
  • 9.6.3 bioMerieux SA
    • 9.6.3.1 Company overview
    • 9.6.3.2 Financial performance
    • 9.6.3.3 Product benchmarking
    • 9.6.3.4 Strategic initiatives
  • 9.6.4 DiaSorin S.p.A.
    • 9.6.4.1 Company overview
    • 9.6.4.2 Financial performance
    • 9.6.4.3 Product benchmarking
    • 9.6.4.4 Strategic initiatives
  • 9.6.5 Danaher Corporation
    • 9.6.5.1 Company overview
    • 9.6.5.2 Financial performance
    • 9.6.5.3 Product benchmarking
    • 9.6.5.4 Strategic initiatives
  • 9.6.6 Thermo Fisher Scientific, Inc.
    • 9.6.6.1 Company overview
    • 9.6.6.2 Financial performance
    • 9.6.6.3 Product benchmarking
    • 9.6.6.4 Strategic initiatives
  • 9.6.7 F. Hoffmann - La Roche Ltd
    • 9.6.7.1 Company overview
    • 9.6.7.2 Financial performance
    • 9.6.7.3 Product benchmarking
    • 9.6.7.4 Strategic initiatives